Placebo-controlled double blinded parallel trial for safety and efficacy evaluation of drink containing with a plant-derived product and carnosine

Phase 1

• Conditions: ot applicable

• Registration Number: JPRN-UMIN000018783
• Lead Sponsor: Suntory Global Innovation Center Ltd.

Brief Summary

npublished

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-08-26
• Study Completion: 2015-11-13
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1) Subjects who take continuous medical treatment. 2) Subjects who have systolic blood pressure less than 90 mmHg. 3) Subjects who are pregnant or have possibility to bocome pregnant or planning to become pregnant during the study or breast-feeding woman. 4) Subjects who donated 200 mL of blood and/or blood components within the last one month prior to the current study. 5) Male subjects who donated 400 mL of blood within the last three months prior to the current study. 6) Female subjects who donated 400 mL of blood within the last four months prior to the current study. 7) Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 8) Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 9) Subjects who are participating in other clinical studies, or who finished clinical study within three months. 10) Subjects who are contracting heart disease, liver disease, kidney disease and digestive disease. 11) Subjects who have contracted a disease in circulatory organs. 12) Subjects who have allergic reaction to drug medicine and food. 13) Subjects who drink alcohol or smoke a lot. 14) Subjects who have an extremely irregular diet habit or alternative work schedule or work on midnight shift. 15) Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 16) Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.

Study & Design

• Study Type: Interventional
• Study Design: Not specified